Press Releases

(BLOOMINGTON, Minn.) October 8, 2026 – Fasikl is pleased to announce that its Co-Founder and Chief Executive Officer, Zhi Yang, PhD, has been named the recipient of the 2026 Wallace H. Coulter Award for Healthcare Innovation by the Biomedical Engineering Society (BMES). The Wallace H. Coulter Award recognizes individuals who have made significant contributions to…

An additional peer-reviewed study also set the first clinical significance threshold for essential tremor scores, a bar Felix’s one-year data clear by more than 50% (MINNEAPOLIS, BUSINESS WIRE) – Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that patients with essential tremor (ET) who used…

The analysis from a randomized clinical trial shows clinically meaningful, statistically significant improvements in daily living and quality of life in essential tremor when using the Felix NeuroAI™ Wristband (MINNEAPOLIS, BUSINESS WIRE) – Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced the publication of data…

(MINNEAPOLIS, Minn.) September 10, 2025 – Fasikl has closed a $26.5 million Series B funding round to accelerate the development and commercialization of next-generation AI therapeutics. The proceeds will support R&D efforts aimed at enhancing efficacy, expanding clinical applications, and improving user experience for upcoming AI therapeutic products targeting essential tremor and other neurological disorders. Funds…

Bloomington’s Fasikl is looking to commercialize its AI-powered wristband treating essential tremor. The device just received FDA clearance. (MINNEAPOLIS, The Minnesota Star Tribune) – Zhi Yang, CEO of Fasikl, recently spoke about the company’s journey from gaming technology to developing a groundbreaking medical device for essential tremor. He described the creation of the Felix NeuroAI™…

Powered by recent breakthroughs in AI technologies, Felix offers a noninvasive, drug-free alternative to surgery and medications, providing all-day relief for adults living with essential tremor (MINNEAPOLIS, BUSINESS WIRE) – Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic medicine and artificial intelligence (AI), today announced that the U.S. Food and Drug Administration…

(MINNEAPOLIS, Minn.) May 21, 2025 – Zhi Yang, CEO of Fasikl, presented at the National Academy of Engineering Regional Meeting at Medtronic Mounds View. The event explored recent advances and future directions in Transforming Healthcare at the Intersection of AI and Medical Devices. Zhi highlighted Fasikl’s leadership in AI therapeutics, showcasing how AI enables personalized, adaptive…

Wristband is a first-of-its-kind investigational wearable designed to provide dynamic, all-day, personalized relief for people with essential tremor (ET); powered by advanced AI to continuously adapt stimulation based on real-time feedback. TRANQUIL study results presented in late-breaker at the 2025 American Academy of Neurology (AAN) annual meeting demonstrate clinically meaningful improvements in ET symptoms and…

(MINNEAPOLIS, Minn.) January 7, 2025 – Fasikl is thrilled to announce our enrollment in the Google for Startups Cloud Program. This prestigious program empowers us to accelerate our position using Google’s leading AI technology and solutions. As an AI startup pioneering Cloud-AI driven therapies, Fasikl has been granted $300,000 in Google Cloud credits along with…

(MINNEAPOLIS, Minn.) September 10, 2024 – Fasikl closes an $18.3 million A+ round investment to develop AI-driven therapeutic technologies. The funds will be allocated to R&D and clinical trials for expanding indications. The round is co-led by iSeed and Tailwinds Ventures.